Literature DB >> 21311231

Plugging PKA into ERK scaffolds.

F Donelson Smith, Lorene K Langeberg, John D Scott.   

Abstract

Cancers often arise in part through derangements in protein kinase signaling. A striking example of this is the finding that approximately 30% of human tumors have mutations in Ras or B-Raf, leading to aberrant ERK kinase activation. Kinase signaling networks are often organized by scaffolding and anchoring proteins that help shape the dynamics of signal processing. AKAP-Lbc associates with the ERK scaffold protein KSR-1 to organize a growth factor and cAMP responsive signaling network. AKAP-Lbc also directs PKA phosphorylation of KSR-1 on a critical residue to ensure maximal signaling efficiency.
© 2011 Landes Bioscience

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21311231      PMCID: PMC3322337          DOI: 10.4161/cc.10.5.14902

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  10 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 2.  Rap1 signalling: adhering to new models.

Authors:  J L Bos; J de Rooij; K A Reedquist
Journal:  Nat Rev Mol Cell Biol       Date:  2001-05       Impact factor: 94.444

Review 3.  Coordinating ERK/MAPK signalling through scaffolds and inhibitors.

Authors:  Walter Kolch
Journal:  Nat Rev Mol Cell Biol       Date:  2005-11       Impact factor: 94.444

Review 4.  Integrating signals between cAMP and the RAS/RAF/MEK/ERK signalling pathways. Based on the anniversary prize of the Gesellschaft für Biochemie und Molekularbiologie Lecture delivered on 5 July 2003 at the Special FEBS Meeting in Brussels.

Authors:  Nicolas Dumaz; Richard Marais
Journal:  FEBS J       Date:  2005-07       Impact factor: 5.542

Review 5.  Discovery and development of sorafenib: a multikinase inhibitor for treating cancer.

Authors:  Scott Wilhelm; Christopher Carter; Mark Lynch; Timothy Lowinger; Jacques Dumas; Roger A Smith; Brian Schwartz; Ronit Simantov; Susan Kelley
Journal:  Nat Rev Drug Discov       Date:  2006-10       Impact factor: 84.694

6.  The C. elegans ksr-1 gene encodes a novel Raf-related kinase involved in Ras-mediated signal transduction.

Authors:  M Sundaram; M Han
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

7.  AKAP-Lbc enhances cyclic AMP control of the ERK1/2 cascade.

Authors:  F Donelson Smith; Lorene K Langeberg; Cristina Cellurale; Tony Pawson; Deborah K Morrison; Roger J Davis; John D Scott
Journal:  Nat Cell Biol       Date:  2010-11-21       Impact factor: 28.824

Review 8.  Cell signaling in space and time: where proteins come together and when they're apart.

Authors:  John D Scott; Tony Pawson
Journal:  Science       Date:  2009-11-27       Impact factor: 47.728

9.  Identification of constitutive and ras-inducible phosphorylation sites of KSR: implications for 14-3-3 binding, mitogen-activated protein kinase binding, and KSR overexpression.

Authors:  A M Cacace; N R Michaud; M Therrien; K Mathes; T Copeland; G M Rubin; D K Morrison
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

10.  Protein kinase A blocks Raf-1 activity by stimulating 14-3-3 binding and blocking Raf-1 interaction with Ras.

Authors:  Nicolas Dumaz; Richard Marais
Journal:  J Biol Chem       Date:  2003-06-11       Impact factor: 5.157

  10 in total
  6 in total

1.  DARPP-32 is required for MAPK/ERK signaling in thyroid cells.

Authors:  Ana Chocarro-Calvo; Miguel A Zaballos; Pilar Santisteban; Custodia García-Jiménez
Journal:  Mol Endocrinol       Date:  2012-02-02

Review 2.  A-kinase anchoring proteins: cAMP compartmentalization in neurodegenerative and obstructive pulmonary diseases.

Authors:  W J Poppinga; P Muñoz-Llancao; C González-Billault; M Schmidt
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

3.  Phosphodiesterase Isoform Regulation of Cell Proliferation and Fluid Secretion in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Cibele S Pinto; Archana Raman; Gail A Reif; Brenda S Magenheimer; Corey White; James P Calvet; Darren P Wallace
Journal:  J Am Soc Nephrol       Date:  2015-08-19       Impact factor: 10.121

4.  Protein Kinase A (PKA) Type I Interacts with P-Rex1, a Rac Guanine Nucleotide Exchange Factor: EFFECT ON PKA LOCALIZATION AND P-Rex1 SIGNALING.

Authors:  Lydia Chávez-Vargas; Sendi Rafael Adame-García; Rodolfo Daniel Cervantes-Villagrana; Alejandro Castillo-Kauil; Jessica G H Bruystens; Shigetomo Fukuhara; Susan S Taylor; Naoki Mochizuki; Guadalupe Reyes-Cruz; José Vázquez-Prado
Journal:  J Biol Chem       Date:  2016-01-21       Impact factor: 5.157

5.  Cre transgene results in global attenuation of the cAMP/PKA pathway.

Authors:  L Gangoda; M Doerflinger; Y Y Lee; A Rahimi; N Etemadi; D Chau; L Milla; L O'Connor; H Puthalakath
Journal:  Cell Death Dis       Date:  2012-08-09       Impact factor: 8.469

Review 6.  Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response.

Authors:  James A McCubrey; Linda S Steelman; William H Chappell; Stephen L Abrams; Giuseppe Montalto; Melchiorre Cervello; Ferdinando Nicoletti; Paolo Fagone; Grazia Malaponte; Maria C Mazzarino; Saverio Candido; Massimo Libra; Jörg Bäsecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Michele Milella; Agostino Tafuri; Lucio Cocco; Camilla Evangelisti; Francesca Chiarini; Alberto M Martelli
Journal:  Oncotarget       Date:  2012-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.